0,973  0,004  Antiinflammatory
0,946  0,002  Nitric oxide antagonist
0,914  0,005  Apoptosis agonist
0,829  0,001  Farnesoid X receptor antagonist
0,808  0,004  Sensitization
0,759  0,004  Tumour necrosis factor alpha release inhibitor
0,752  0,009  Antileukemic
0,732  0,006  Bone diseases treatment
0,717  0,005  Metabolic disease treatment
0,715  0,019  Transcription factor NF kappa B inhibitor
0,673  0,005  Apoptosis antagonist
0,667  0,007  Antiosteoporotic
0,663  0,007  Immunosuppressant
0,623  0,009  Antineoplastic (pancreatic cancer)
0,642  0,028  Antineoplastic (breast cancer)
0,622  0,010  Immunomodulator
0,610  0,004  Transcription factor STAT inhibitor
0,607  0,004  Transcription factor STAT3 inhibitor
0,601  0,005  Antiulcerative
0,621  0,027  Antineoplastic (lung cancer)
0,595  0,010  Antipsoriatic
0,600  0,019  Antibacterial
0,564  0,014  Antioxidant
0,560  0,017  Antipruritic, allergic
0,517  0,005  Platelet adhesion inhibitor
0,520  0,016  Antineoplastic (glioma)
0,538  0,037  TNF expression inhibitor
0,492  0,005  Antiviral (Influenza)
0,476  0,007  Interferon gamma antagonist
0,496  0,028  Antineoplastic (ovarian cancer)
0,476  0,015  Antineoplastic (lymphoma)
0,468  0,013  Antineoplastic (liver cancer)
0,461  0,008  Contraceptive
0,473  0,021  Antineoplastic (multiple myeloma)
0,458  0,019  Antineoplastic (glioblastoma multiforme)
0,455  0,030  Cytotoxic
0,428  0,009  Prostate disorders treatment
0,449  0,031  Antineoplastic (melanoma)
0,457  0,042  Antineoplastic (colorectal cancer)
0,440  0,042  Antineoplastic (colon cancer)
0,429  0,033  Radioprotector
0,405  0,010  Antiacne
0,465  0,075  Caspase 9 stimulant
0,413  0,035  ICAM1 expression inhibitor
0,428  0,055  CYP3A4 substrate
0,410  0,042  Antifungal
0,387  0,033  Antiprotozoal (Leishmania)
0,386  0,035  Cytostatic
0,398  0,052  Prostate cancer treatment
0,392  0,046  Hepatic disorders treatment
0,370  0,026  Antineoplastic (endocrine cancer)
0,372  0,030  Antineoplastic (renal cancer)
0,383  0,045  AR expression inhibitor
0,351  0,016  Prostatic (benign) hyperplasia treatment
0,376  0,045  NOS3 expression inhibitor
0,364  0,039  NOS2 expression inhibitor
0,372  0,050  Respiratory analeptic
0,324  0,011  Antidiabetic (type 1)
0,326  0,018  Antialcoholic
0,347  0,040  Proliferative diseases treatment
0,290  0,003  Hypercalcemia treatment
0,312  0,026  Hepatoprotectant
0,299  0,018  Sepsis treatment
0,316  0,040  Chemopreventive
0,326  0,051  UGT2B4 substrate
0,358  0,088  Antiprotozoal
0,290  0,023  Antineoplastic (carcinoma)
0,330  0,064  Calcium channel activator
0,279  0,026  Antipruritic, non-allergic
0,245  0,003  Lysine-specific demethylase 1A inhibitor
0,311  0,069  Analeptic
0,270  0,034  UGT2B7 substrate
0,247  0,018  Antifungal enhancer
0,237  0,012  Microtubule formation inhibitor
0,282  0,063  Antineoplastic (cervical cancer)
0,312  0,099  CYP2C9 substrate
0,294  0,081  Antimycobacterial
0,235  0,029  Antiviral (Influenza A)
0,252  0,047  Abortion inducer
0,276  0,072  Renal disease treatment
0,286  0,086  Caspase 3 stimulant
0,229  0,035  Antineoplastic (squamous cell carcinoma)
0,292  0,104  Antiprotozoal (Plasmodium)
0,238  0,053  UDP-glucuronosyltransferase substrate
0,281  0,097  Sodium/bile acid cotransporter inhibitor
0,179  0,002  Vitamin D receptor antagonist
0,180  0,007  Anabolic
0,175  0,002  Progesterone agonist
0,210  0,038  Protein kinase stimulant
0,224  0,055  Pneumotoxic
0,253  0,089  Antituberculosic
0,223  0,062  Carcinogenic
0,167  0,009  Paget's disease treatment
0,237  0,080  Cardiovascular analeptic
0,237  0,084  Antipyretic
0,205  0,053  Lipocortins synthesis antagonist
0,242  0,090  Chemoprotective
0,202  0,051  Antineoplastic (gastric cancer)
0,230  0,079  Angiogenesis stimulant
0,191  0,042  Arachidonic acid antagonist
0,193  0,049  Protein-tyrosine phosphatase inhibitor
0,215  0,073  Antineoplastic enhancer
0,225  0,084  Teratogen
0,179  0,038  Cyclooxygenase 2 inhibitor
0,231  0,094  Interleukin agonist
0,203  0,069  Non-steroidal antiinflammatory agent
0,140  0,008  Na+ K+ transporting ATPase inhibitor
0,201  0,071  UGT1A1 substrate
0,153  0,031  Contraceptive female
0,131  0,012  T cell inhibitor
0,182  0,067  UGT1A4 substrate
0,152  0,038  Ca2+-transporting ATPase inhibitor
0,144  0,032  Antineoplastic antibiotic
0,223  0,112  CYP2C19 substrate
0,240  0,130  Interleukin 2 agonist
0,112  0,003  Parathyroid hormone antagonist
0,165  0,060  Cyclooxygenase inhibitor
0,181  0,079  Antihelmintic
0,169  0,069  UGT2B10 substrate
0,193  0,095  Embryotoxic
0,127  0,029  Actinic keratosis treatment
0,125  0,027  ABCA1 expression enhancer
0,208  0,112  DNA synthesis inhibitor
0,113  0,022  CDC25A inhibitor
0,118  0,027  Ornithine decarboxylase inhibitor
0,147  0,058  Pregnane X receptor agonist
0,157  0,072  Melanin inhibitor
0,238  0,153  Stroke treatment
0,145  0,067  Antifungal (Cryptococcus)
0,179  0,103  Antiparasitic
0,201  0,125  Antineoplastic (sarcoma)
0,151  0,076  UGT2B9 substrate
0,147  0,072  UGT2B15 substrate
0,209  0,135  5 Hydroxytryptamine uptake stimulant
0,201  0,127  UGT1A9 substrate
0,256  0,182  Transcription factor inhibitor
0,105  0,032  Antibiotic
0,114  0,043  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,094  0,023  Aromatase inhibitor
0,101  0,031  Glycine receptor antagonist
0,099  0,031  Keratolytic
0,174  0,105  Neurotrophic factor enhancer
0,081  0,013  Postcoital contraceptive
0,071  0,004  CYP24 inhibitor
0,214  0,151  Antineoplastic (brain cancer)
0,121  0,062  Protein-tyrosine phosphatase 1B inhibitor
0,088  0,030  Glycine receptor agonist
0,133  0,076  Antieczematic
0,097  0,042  Contraceptive male
0,068  0,014  5-Alpha-reductase inhibitor
0,103  0,053  UGT2B11 substrate
0,058  0,009  Endothelin receptor antagonist
0,052  0,005  Endothelin B receptor antagonist
0,099  0,052  Bile acid receptor antagonist
0,121  0,077  Acetylcholinesterase inhibitor
0,132  0,090  Genotoxic
0,058  0,015  Progesterone antagonist
0,168  0,129  UGT1A6 substrate
0,064  0,028  Lipocortins synthesis agonist
0,049  0,014  RNA-directed RNA polymerase stimulant
0,080  0,046  Narcotic antagonist
0,063  0,030  Postmenopausal disorders treatment
0,112  0,080  Growth stimulant
0,040  0,008  Endothelin A receptor antagonist
0,054  0,023  Microtubule stabilization
0,043  0,013  Tubulin agonist
0,059  0,030  Estrogen agonist
0,208  0,179  GST M1-1 substrate
0,064  0,036  Heme oxygenase stimulant
0,130  0,102  Adenylate cyclase stimulant
0,086  0,058  Transcription factor NF kappa B stimulant
0,061  0,035  Ryanodine receptor antagonist
0,179  0,154  Cardioprotectant
0,030  0,005  Progesterone receptor B antagonist
0,099  0,075  Choleretic
0,065  0,044  Hyperparathyroidism treatment
0,247  0,226  Autoimmune disorders treatment
0,122  0,103  Antidote
0,066  0,048  Glutamate (mGluR6) antagonist
0,163  0,145  VCAM1 expression inhibitor
0,080  0,066  Antineoplastic alkaloid
0,109  0,096  Bone formation stimulant
0,051  0,039  Protein 50S ribosomal subunit inhibitor
0,078  0,068  Androgen antagonist
0,049  0,039  Anesthetic inhalation
0,066  0,056  SULT2A1 substrate
0,117  0,108  Diuretic
0,102  0,094  Estrogen antagonist
0,017  0,010  Vitamin D receptor agonist
0,008  0,002  Vitamin D-like
0,065  0,060  Lipase inhibitor
0,020  0,017  Corticosteroid-like
0,049  0,046  Nicotinic alpha3beta2 receptor antagonist

